LONDON – The European Union is being urged to adopt urgent measures to reduce the bloc’s dependency on imports of pharmaceutical ingredients from China, thereby shoring up Europe’s medical supply resilience and avoiding future drug shortages.
In a confidential policy paper leaked to the media, 19 out of the EU’s current 27 member-states are asking the European Commission, the Union’s executive body, to adopt a so-called Critical Medicines Act that would encourage the production of crucial medicine on the continent, similar to the way the Commission is now pushing towards Europe’s self-reliance in microchips.
Already a subscriber? Log in
Read the full story and more at $9.90/month
Get exclusive reports and insights with more than 500 subscriber-only articles every month
ST One Digital
$9.90/month
No contract
ST app access on 1 mobile device
Unlock these benefits
All subscriber-only content on ST app and straitstimes.com
Easy access any time via ST app on 1 mobile device
E-paper with 2-week archive so you won't miss out on content that matters to you